ImmuCell Corporation
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +500.0% | +13.3% | -88.0% | +1,011.6% | +109.5% | -26.0% | -3.3% | -43.7% | +77.6% | -74.3% | -84.8% | -306.4% | – | – | – | +219.0% | -72.5% | +859.2% | -111.2% | – | -131.8% | – | +463.4% | -27.5% | -261.8% | – | – | +591.6% | |
| – | +0.0% | +0.0% | +1.5% | +31.1% | +32.9% | +33.8% | +8.2% | +8.7% | +131.1% | -56.7% | +183.2% | -49.4% | +6.3% | -1.2% | -0.3% | -3.8% | +3.6% | +7.6% | +17.9% | +51.6% | +12.7% | +68.1% | +49.1% | +3.5% | +4.9% | +1.1% | +9.2% | -1.1% | +1.6% | |
| – | – | – | – | – | – | – | – | – | – | – | +128.0% | +738.4% | +70.1% | -68.6% | +29.3% | -5.7% | -12.9% | -4.3% | -22.6% | +190.2% | +196.4% | +72.2% | -9.0% | -19.2% | -43.0% | +84.5% | +38.5% | -11.6% | -9.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +17.9% | -135.2% | – | -59.8% | -121.3% | – | +186.1% | -280.4% | – | +154,415.2% | – | – | – | |
| – | – | – | -114.0% | – | – | +240.5% | +121.4% | +119.5% | -179.0% | – | -276.0% | – | -284.7% | – | – | -240.0% | – | -81.8% | +324.6% | -723.3% | – | -43.2% | -462.0% | – | -404.8% | – | – | – | – | |
| – | -75.0% | +0.0% | +31.6% | +108.8% | +226.1% | -72.1% | +21.7% | +11.2% | -45.3% | +604.0% | +17.2% | -73.1% | +11.9% | -74.6% | +109.1% | +13.0% | +117.0% | +156.9% | +77.1% | +31.9% | +395.2% | -88.6% | -31.5% | +192.7% | -35.9% | +52.4% | -52.4% | -75.4% | +168.5% | |
| – | -80.0% | – | – | -21.5% | +210.9% | +7.4% | -60.8% | +679.4% | -56.4% | +129.1% | -84.8% | -90.5% | +369.9% | – | -548.4% | – | -180.8% | +14.4% | +200.8% | -4.3% | +177.5% | -85.4% | +89.7% | -24.5% | -37.8% | +148.2% | -52.3% | -75.6% | +163.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -65.0% | -57.2% | -85.5% | +3,717.4% | +6,976.1% | -55.1% | -97.5% | +8,526.6% | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -138.0% | +5.0% | +4.9% | – | -108.0% | – | -86.6% | -271.6% | – | -118.7% | – | -99.8% | -180.9% | +0.7% | |
| – | +100.0% | -150.0% | -99.7% | – | -85.0% | -969.9% | – | +6,104.2% | -21.9% | +28.0% | -116.7% | – | +5,033,450.0% | +859.2% | -36.4% | -118.7% | +38.8% | +17.5% | – | +240.8% | +17.1% | -90.9% | +680.3% | -72.5% | +103.0% | -71.3% | +57.2% | +64.6% | -142.1% | |
| – | – | +150.0% | -43.0% | -74.9% | -116.8% | – | +111.6% | -265.5% | – | – | – | – | -3,177.9% | – | -245.8% | – | -121.3% | – | – | +394.5% | -137.8% | – | – | -82.6% | +392.7% | -235.8% | – | – | -98.3% | |
| – | – | – | +9.6% | -135.3% | – | +16,383.8% | -33.3% | -7.3% | -43.2% | -90.5% | -2,249.8% | – | – | – | – | – | +626.1% | -346.2% | – | -2,259.8% | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.